Victhom Human Bionics Inc. (TSXV:VHB)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Victhom Human Bionics Inc. Charts. Click Here for more Victhom Human Bionics Inc. Charts.](/p.php?pid=staticchart&s=TX%5EVHB&p=8&t=15)
QUEBEC, June 21, 2011 /CNW/ --
QUEBEC, June 21, 2011 /CNW Telbec/ - Victhom Human Bionics Inc.
("Victhom") (TSXV: VHB) today reported the results of its Annual
General Meeting of shareholders held in Montreal, Quebec.
The shareholders approved the motions put forth at the meeting to
re-appoint the four directors of the Company: Messrs Daniel Johnson,
Nitin Kaushal, Martin Leblanc and Normand Rivard and to appoint Ernst &
Young LLP as the Company's auditors.
At their meeting held directly following the Annual General Meeting, the
directors re-appointed Mr. Daniel Johnson as Chairman of the Board.
About Victhom
Victhom is a company which owns patents in the field of orthotics and
prosthetics ("O&P), including intellectual property used in the Power
Knee, the world's first and only motor-powered prosthesis for
above-knee amputees, a product distributed under license agreement by
Ossur, a global leader in the O&P market. The Company also has a
royalty agreement related to the Neurostep(®) System and neuromodulation products in other indications (sleep apnea
and epilepsy) using the Neurobionix technology platform currently under
development by Neurostream Technologies, a General Partnership now
owned by Otto Bock, a global leader in the O&P market.
FORWARD-LOOKING STATEMENTS
Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future
financial performance and involve known and unknown risks,
uncertainties and other factors that may cause Victhom's actual
results, performance or achievements to be materially different from
those expressed or implied by any of Victhom's statements. Actual
events or results may differ materially. We disclaim any intention, and
assume no obligation, to update these forward-looking statements.
To view this news release in HTML formatting, please use the following URL: http://www.cnw.ca/en/releases/archive/June2011/21/c8163.html
table valign="top" border="0" tr td valign="top" align="left" bSource:/b /td td Victhom Human Bionics Inc. /td /tr tr td valign="top" align="left" bFor more information:/b br/ br/ br/ /td td Normand Rivardbr/ President & CEObr/ Victhom Human Bionics Inc.br/ Tel.: 418-872-5665 ext 107br/ Fax: 418-864-7034br/ ia cr="true" href="mailto:normand.rivard@victhom.com"normand.rivard@victhom.com/a/i /td /tr tr td valign="top" align="left" /td td ia cr="true" href="http://www.victhom.com/"www.victhom.com/a/i /td /tr /table p /p